Impact of tuberculosis on the body composition of HIV-infected men in Brazil

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 3, 1999, Pages 265-271

  Paton, Nicholas I ^a,d   Castello Branco, Luiz R ^b   Jennings, Graham ^c   Ortigao de Sampaio, Maria B ^b   Elia, Marinos ^c   Costa, Stephen ^a   Griffin, George E ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Body cell mass; Body composition; HIV infection; Malnutrition; Tuberculosis

Indexed keywords

ARTICLE; BODY COMPOSITION; BRAZIL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERMETABOLISM; LYMPHOCYTE COUNT; MALE; NUTRITIONAL STATUS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TUBERCULOSIS; WASTING SYNDROME;

ACTINOBACTERIA (CLASS); HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; UNCULTURED ACTINOMYCETE;

EID: 0032920346     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199903010-00008     Document Type: Article

References (47)

1. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993; 58:417-24.
2. Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997;11(Suppl B):S43-54.
3. Lucas SB, De Cock KM, Hounnou A, et al. Contribution of tuberculosis to slim disease in Africa. BMJ 1994;308:1531-3.
4. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:239-46.
5. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
6. Keusch GT, Thea DM. Malnutrition in AIDS. Med Clin North America 1993;77:795-815.
7. Paton NIJ, Macallan DC, Jebb SA, et al. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:119-27.
8. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:43-8.
9. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255-65.
10. Ott M, Lembcke B, Fischer H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993;57:15-19.
11. Juffermans NP, Verbon A, van Deventer SJH, van Deutekom H, Speelman P, van der Poll T. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 1998;157:1328-31.
12. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1.
13. 2O and infrared absorption of biological fluids. Am J Clin Nutr 1985;41:363-70.
14. Vaisman N, Pencharz PB, Koren G, Johnson J. Comparison of oral and intravenous administration of sodium bromide for extracellular water measurements. Am J Clin Nutr 1987;46:1-4.
15. Halliday D, Millar DG. Precise measurement of total body water using tracer quantities of deuterium oxide. Mass Spectrom 1977; 4:82-7.
16. 2 labelled water. Clin Nutr 1980;33:2686-93.
17. Jennings G, Elia M. Automated assay of plasma bromide after a single deproteinization step. Clin Chem 1996;42:1210-13.
18. Trapp SA, Bell EF. An improved spectrophotometric bromide assay for the estimation of extracellular water volume. Clin Chim Acta 1989;181:207-12.
19. Barac-Nieto M, Spurr GB, Lotero H, Maksud MG. Body composition in chronic undernutrition. Am J Clin Nutr 1978;31:23-40.
20. Pace N, Rathbun EN. Studies on body composition. III. The body water and chemically combined nitrogen content in relation to fat content. J Biol Chem 1945;158:685-91.
21. Cornish BH, Ward LC, Thomas BJ, Jebb SA, Elia M. Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans. Eur J Clin Nutr 1996;50:159-64.
22. Paton NI, Elia M, Jennings G, Ward LC, Griffin GE. Bioelectrical impedance analysis in HIV-infected patients:comparison of single frequency with multifrequency, spectroscopy and other novel approaches. Nutrition 1998;14:658-66.
23. Paton NIJ, Macallan DC, Griffin GE, Pazianas M. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997;61:30-2.
24. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MR, Boyden CM. The body cell mass and its supporting environment: body composition in health and disease. Philadelphia: WB Saunders, 1963.
25. McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med 1995;333:1260-6.
26. Haussinger D, Roth E, Lang F, Gerok W. Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet 1993;341:1330-2.
27. Finn PJ, Plank LD, Clark MA, Connolly AB, Hill GL. Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 1996;347:654-6.
28. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Ann Intern Med 1997;125: 873-82.
29. Paton NIJ, Newton PJ, Noble C, et al. Anthropometric prediction of limb muscle mass [abstract]. Nutrition 1997;13:279.
30. Scalcini M, Occenac R, Manfreda J, Long R. Pulmonary tuberculosis, human immunodeficiency virus type-1 and malnutrition. Bull Int Union Tuberc Lung Dis 1991;66:37-41.
31. Grunfeld C, Pang M, Shimuzu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55: 455-60.
32. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83-8.
33. Forbes GB. Lean body mass-body fat interrelationships in humans. Nutr Rev 1987;45:225-31.
34. Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL. The biology of human starvation. Minneapolis: University of Minnesota Press, 1950.
35. Wallis RS, Vjecha M, Manijeh A-T, et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta-2 microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993;167:43-8.
36. Macallan DC, McNurlan MA, Kurpad AV, et al. Whole body protein metabolism in human pulmonary tuberculosis and under-nutrition: evidence for anabolic block in tuberculosis. Clin Sci 1998;94:321-31.
37. Turner J, Muurahainen N, Terrell C, Graeber C, Kotler D. Nutritional status and quality of life [abstract]. Int Conf AIDS 1994;10: 35.
38. Whalen C, Horsburgh CR, Horn D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. J Respir Crit Care Med 1995;151:129-35.
39. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.
40. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8.
41. Garrait V, Cadranel J, Esvant H, et al. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol 1997;159:2824-30.
42. Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg 1996;90: 162-6.
43. Kotler DP, Tierney AR, Altilio D, Wang J, Pierson RN. Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989;149:901-5.
44. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN, Jr. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enterai Nutr 1990;14:454-8.
45. Klausner JD, Makonkawkeyoon S, Akarasewi P, et al. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:247-57.
46. Haslett P, Hempstead M, Seidman C, et al. The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Res Hum Retrovirol 1997;13:1047-54.
47. Paton N, Newton P, Ross H, et al. Growth hormone therapy during acute opportunistic infections in AIDS has a protein-sparing effect. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada 1997;I-22.